This Article Full Text Full Text (PDF) All Versions of this Article: biophysj.107.114868v1 93/11/3835    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Grandi, E. Articles by Bers, D. M. Search for Related Content PubMed PubMed Citation Articles by Grandi, E. Articles by Bers, D. M.

Simulation of Ca-Calmodulin-Dependent Protein Kinase II on Rabbit Ventricular Myocyte Ion Currents and Action Potentials

Eleonora Grandi ^* , Jose L. Puglisi , Stefan Wagner , Lars S. Maier , Stefano Severi ^* and Donald M. Bers 

^* Biomedical Engineering Laboratory, Department of Electronics, Computer Science and Systems, University of Bologna, Bologna, Italy; Department of Physiology, Loyola University, Chicago, Illinois; and Department of Cardiology and Pneumology, Georg-August-University, Göttingen, Germany

Correspondence: Address reprint requests to Donald M. Bers, PhD, Dept. of Physiology, Loyola University, Chicago, Stritch School of Medicine, 2160 South First Ave., Maywood, IL 60153. Tel.: 708-216-1018; Fax: 708-216-6308; E-mail: dbers{at}lumc.edu.

Ca-calmodulin-dependent protein kinase II (CaMKII) was recently shown to alter Na⁺ channel gating and recapitulate a human Na⁺ channel genetic mutation that causes an unusual combined arrhythmogenic phenotype in patients: simultaneous long QT syndrome and Brugada syndrome. CaMKII is upregulated in heart failure where arrhythmias are common, and CaMKII inhibition can reduce arrhythmias. Thus, CaMKII-dependent channel modulation may contribute to acquired arrhythmic disease. We developed a Markovian Na⁺ channel model including CaMKII-dependent changes, and incorporated it into a comprehensive myocyte action potential (AP) model with Na⁺ and Ca²⁺ transport. CaMKII shifts Na⁺ current (I_Na) availability to more negative voltage, enhances intermediate inactivation, and slows recovery from inactivation (all loss-of-function effects), but also enhances late noninactivating I_Na (gain of function). At slow heart rates, with long diastolic time for I_Na recovery, late I_Na is the predominant effect, leading to AP prolongation (long QT syndrome). At fast heart rates, where recovery time is limited and APs are shorter, there is little effect on AP duration, but reduced availability decreases I_Na, AP upstroke velocity, and conduction (Brugada syndrome). CaMKII also increases cardiac Ca²⁺ and K⁺ currents (I_Ca and I_to), complicating CaMKII-dependent AP changes. Incorporating I_Ca and I_to effects individually prolongs and shortens AP duration. Combining I_Na, I_Ca, and I_to effects results in shortening of AP duration with CaMKII. With transmural heterogeneity of I_to and I_to downregulation in heart failure, CaMKII may accentuate dispersion of repolarization. This provides a useful initial framework to consider pathways by which CaMKII may contribute to arrhythmogenesis.